Patent Assignment
Reel/Frame 030495/0583
Assignment of Assignor's Interest
Recorded: 2013-05-28
Pages: 4
Assignor
ISIS PHARMACEUTICALS INC.
Executed: 2007-11-08
Assignee
REGULUS THERAPEUTICS, LLC
1896 RUTHERFORD ROAD, CARLSBAD, CALIFORNIA, 92008
Covered Property
(1)
Method of Inhibiting Mir-33 Using a Modified Oligonucleotide
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 28, 2013
From: ESAU, CHRISTINE; LOLLO, BRIDGET; BENNETT, C. FRANK; FREIER, SUSAN M.
To: ISIS PHARMACEUTICALS INC.
Reel/Frame 030495/0443 →
Change of Name
May 28, 2013
From: REGULUS THERAPEUTICS, LLC
To: REGULUS THERAPEUTICS INC.
Reel/Frame 030498/0602 →
Security Interest
Aug 8, 2018
From: REGULUS THERAPEUTICS INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT AND LENDER
Reel/Frame 046748/0561 →
Release of Security Interest
May 14, 2024
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT AND LENDER
To: REGULUS THERAPEUTICS INC.
Reel/Frame 067402/0782 →